Impact of global work index on obesity paradox in heart failure with advanced left ventricle remodeling

Roubai Pan1, Xierenayi Tudi1, Weiwei Jiang1

  • 1Department of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Insights

In heart failure patients with advanced left ventricular remodeling, higher myocardial work (global work index) modifies the obesity paradox, suggesting obesity may be protective. This highlights the importance of considering myocardial function when assessing prognosis.

Area of Science:

  • Cardiology
  • Heart Failure Research
  • Obesity Medicine

Background:

  • The obesity paradox in heart failure suggests lower body mass index (BMI) is associated with worse outcomes.
  • Advanced left ventricular remodeling is a key factor in heart failure prognosis.
  • The role of myocardial work in this paradox remains unclear.

Purpose of the Study:

  • To investigate the influence of myocardial work, specifically the global work index (GWI), on the obesity paradox in heart failure patients with advanced left ventricular remodeling.
  • To assess the prognostic impact of obesity at different GWI levels in this patient population.

Main Methods:

  • A post hoc analysis of 515 heart failure patients (LVEF ≤50%) hospitalized between May 2016 and December 2020.
  • Advanced left ventricular remodeling defined by left ventricular mass index (LVMI).
  • Primary endpoint: major adverse cardiovascular events (MACE). Prognostic impact of BMI and GWI assessed.

Main Results:

  • Of 515 patients, 330 had advanced left ventricular remodeling (LVMI thresholds met).
  • In this subgroup, BMI ≥28 kg/m² was linked to lower MACE risk.
  • Higher GWI subgroup (n=139) showed reduced MACE with higher BMI; no association in lower GWI subgroup (n=191).

Conclusions:

  • Myocardial work index significantly modifies the relationship between BMI and prognosis in heart failure.
  • GWI is a crucial factor for evaluating the obesity paradox in patients with left ventricular systolic dysfunction and advanced remodeling.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.2K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
486
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
439
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
734
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.1K